States with robust tobacco control policies and regulations, such as smoke free air laws and taxes on cigarettes, not only have fewer cigarette users but also fewer e-cigarette users, according to research from NYU School of Medicine and the NYU College of Global Public Health.
A new computational resource called Recon3D provides a 3D view of genes, proteins and metabolites involved in human metabolism. Researchers used the tool to map disease-related mutations on proteins and also probed how genes and proteins change in response to certain drugs. The work provides a better understanding of disease-causing mutations and could enable researchers to discover new uses for existing drug treatments.
Critically ill patients who experience long periods of hypoxic, septic or sedative-associated delirium, or a combination of the three, during an intensive care unit (ICU) stay are more likely to have long-term cognitive impairment one year after discharge from the hospital, according to a new study.
Yarn weaved from carbon nanotubes monitors brain control of organ functions in rats, paves way for disease diagnosis and treatment at single nerve level.
Eating a diet that emphasizes vegetables, fruit and whole grains it may lead to a reduced risk of depression, according to a study by researchers at Rush University Medical Center. Study author Dr. Laurel Cherian will present a preliminary study abstract with these conclusions during the American Academy of Neurology’s 70th Annual Meeting in Los Angeles from April 21 to 27, 2018.
Northwestern University researchers have developed a new “smell virtual landscape” that enables the study of how smells engage the brain’s navigation system. The work demonstrates, for the first time, that the mammalian brain can form a map of its surroundings based solely on smells. The olfactory-based virtual reality system could lead to a fuller understanding of odor-guided navigation and explain why mammals have an aversion to unpleasant odors, an attraction to pheromones and an innate preference to one odor over another.
The finding “opens up a whole new research area to look at neuroinflammation in the context of Alzheimer’s and Parkinson’s,” the lead researcher says. “But the clinical impact will be in many, many different areas.”
Research led by Johns Hopkins physicians and scientists shows that a test for measuring the length of DNA endcaps, called telomeres, which has a variability rate of 5 percent, can alter treatment decisions for patients with certain types of bone marrow failure.
Michelle Ozbun, PhD, is using two grants totaling $2.7 million to learn how human papillomaviruses (HPV) sneak into cells to reproduce. She and her team are also developing new ways in which to measure infections.
Researchers at New York University College of Dentistry, in collaboration with Rheonix, Inc., are developing a novel test for Zika virus that uses saliva to identify diagnostic markers of the virus in a fraction of the time of current commercial tests.
Researchers studying a rare genetic disorder that causes severe, progressive neurological problems in childhood have discovered insights into biological mechanisms that drive the disease, along with early clues that an amino acid supplement might offer a targeted therapy.
To treat cardiovascular disease, surgery can remove blockages in large vessels in the heart or legs but is not possible in small vessels. To address this problem, researchers designed 3D-printed patches seeded with vessel-inducing endothelial cells. In a mouse model of hindlimb ischemia, the researchers identified specific patch patterns that induced growth of organized, tissue-saving blood vessels, demonstrating the potential for the novel technology to address this significant public health problem.
During the West African Ebola outbreak that began in 2013, an experimental biopharmaceutical drug called ZMappTM was a glimmer of hope in the midst of a health crisis. Now, scientists at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers of ZMapp, Mapp Biopharmaceutical, Inc., to further test this promising new therapeutic.
Tim Goetz drives about 200,000 miles each year. Remarkably, Goetz is legally blind. Research funded by the National Eye Institute (NEI) is helping Goetz and others like him get or stay behind the wheel while keeping roads safe for everyone.
A team from The Scripps Research Institute (TSRI) has revealed that by crossing two species of flies, they can use what they learn from the proteome of the hybrid offspring to find new clues about how proteins interact with each other
An international team of researchers led by a Case Western Reserve University School of Medicine scientist has uncovered a novel mechanism in which a protein—neuregulin 3—controls how key neurotransmitters are released in the brain during schizophrenia. The protein is elevated in people with schizophrenia and other severe mental illnesses, but the study is the first to investigate how it causes such severe mental illness.
Paul Marvar, PhD, at GW School of Medicine and Health Sciences, received a large grant from the NIH to study a possible link between post-traumatic stress disorder and cardiovascular disease.
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration process called senescence. Now, researchers at the Johns Hopkins Kimmel Cancer Center demonstrated that instead, tumor-associated epigenetic states evolve erratically during early stages of tumor development, eventually selecting for a subset of genes that undergo the most changes during normal aging and in early tumor development.
In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other institutions worldwide discovered changes to five new regions in the human genome that may increase the risk of pancreatic cancer.
Treating food allergies might be a simple matter of teaching the immune system a new trick, researchers at Duke Health have found. In a study using mice bred to have peanut allergies, the Duke researchers were able to reprogram the animals' immune systems using a nanoparticle delivery of molecules to the lymph nodes that switched off the life-threatening reactions to peanut exposures.
Lingering inflammation after heart attack can lead heart failure. It can also claim another victim — the kidneys. New research shows that a bioactive compound called resolvin D-1, injected as a therapeutic dose, is able to limit this collateral damage in the kidneys, as tested in an animal model.
Researchers describe the role of a transcription factor called TCF-1 in targeting the condensed chromatin and regulating the availability of genome sequences in T-cell development. The new connection between TCF-1 and chromatin will aid in developing new therapies using epigenetic drugs to alter T-cell fate in cancer, autoimmune disorders, and infectious diseases.
Researchers engineered mice in which the damage caused by a mutant human TDP-43 protein could be reversed by one type of brain immune cell. TDP-43 is a protein that misfolds and accumulates in the motor areas of the brains of ALS patients. They found that microglia, the first and primary immune response cells in the brain and spinal cord, are essential for dealing with TDP-43-associated neuron death.
Studies have shown that talking with teens about sex-related topics is a positive parenting practice that facilitates important sexual health outcomes with heterosexual adolescents. But for LGBTQ youth, the topic of sexuality and sexual health is often ineffectively addressed at home.
The Biospecimen Core Resource (BCR) in The Research Institute at Nationwide Children’s Hospital has received a new $4.5 million federal contract — with the potential of reaching more than $49.9 million over five years — to accept, process, ensure quality, and distribute tumor derivatives for a number of national cancer research projects. The BCR is part of a national processing and analysis pipeline supporting large scale cancer genomic projects.
African Americans with atrial fibrillation (AF) – a quivering or irregular heartbeat that can lead to a host of dangerous complications – have a significantly higher risk of stroke than Caucasians with the condition, according to new research published today in HeartRhythm by researchers from the Perelman School of Medicine at the University of Pennsylvania. The new findings build on previous studies examining the impact of race on the risk of developing atrial fibrillation (AF), which is linked to blood clots, stroke, heart failure and other complications. It’s well reported that African Americans have a lower risk of developing AF as compared to Caucasians, but until now, there was little data on the additional risks that come with AF for each race.
Around the clock, cells deep in the brain produces a “grandfather” form of several hormones that help us regulate our appetite and eating. Now, a new discovery sheds new light on how that grandfather molecule gets produced – and more important, what can go wrong and raise the risk of overeating and obesity. The findings could pave the way for new approaches to treating forms of obesity, especially those with genetic roots.
A new login authentication approach could improve the security of current biometric techniques that rely on video or images of users’ faces. Known as Real-Time Captcha, the technique uses a unique “challenge” that’s easy for humans — but difficult for attackers who may be using machine learning and image generation software to spoof legitimate users.
The pursuit of the usual suspect in Alzheimer's research may be distracting from a more direct culprit in the disease, according to a study that analyzed data from 51 published experiments. P-tau looked a good bit more culpable than amyloid-beta plaque.
Computers have helped researchers develop a new phosphor that can make LEDs cheaper and render colors more accurately. An international team led by engineers at UC San Diego first predicted the new phosphor using supercomputers and data mining algorithms, then developed a simple recipe to make it in the lab. Unlike many phosphors, this one is made of inexpensive, earth-abundant elements and can easily be made using industrial methods. As computers predicted, the new phosphor performed well in tests and in LED prototypes.
Researchers have shown for the first time that a key protein called KMT2D involved in the epigenetic regulation of gene expression guides this renewal.
Researchers at The Scripps Research Institute (TSRI) have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties.
Asthma is a chronic inflammatory disease driven by the interplay of genetics, environmental factors and a diverse cast of immune cells. In their latest study, researchers at La Jolla Institute for Allergy and Immunology (LJI) identified a subset of T cells, whose frequency serves as early childhood immune signature that predicts the risk of developing asthma later on.
An antibody used to treat the skin disease psoriasis is also effective at reducing aortic inflammation, a key marker of future risk of major cardiovascular events.
Children who have heart surgery as infants are at risk for hearing loss, coupled with associated risks for language, attention and cognitive problems, by age four. In a single-center group of 348 preschoolers who survived cardiac surgery, researchers found hearing loss in about 21 percent, a rate 20 times higher than is found in the general population.
Researchers at The University of Alabama hope to better understand how bacteria and viruses battle each other and, in the process, devise new strategies to combat antibiotic-resistant infections.
A study from scientists at The Scripps Research Institute (TSRI) explains why the risk of osteoarthritis increases as we age and offers a potential avenue for developing new therapies to maintain healthy joints.
A team of researchers from the Cleveland Clinic Lerner Research Institute have found that gradually depleting an enzyme called BACE1 completely reverses the formation of amyloid plaques in the brains of mice with Alzheimer’s disease, thereby improving the animals’ cognitive function. The study, which will be published February 14 in the Journal of Experimental Medicine, raises hopes that drugs targeting this enzyme will be able to successfully treat Alzheimer’s disease in humans.
NIH-supported researchers at Massachusetts General Hospital are studying an alternative to current contrast agents used for magnetic resonance imaging. In a recent study, they showed that the experimental alternative, which is a manganese-based compound, performs as well as approved contrast agents. Their study appeared online Nov. 15, 2017, in Radiology.
Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug.
People with a mutated ATF6 gene have a malformed or missing fovea, severely limiting vision. UC San Diego School of Medicine researchers first linked ATF6 to this type of vision impairment. Now the team discovered that a chemical that activates ATF6 converts patient stem cells into blood vessels.
LJI researchers report mechanisms used by a subgroup of ILCs, known as ILC2 cells, to undergo maturation required for them to mount an effective immune response. These discoveries suggest a novel approach to treat inflammatory disease caused by overactive ILC2s.
Exercise has numerous, well-documented health benefits. Could it also play a role in preventing and reducing substance misuse and abuse in adolescents? This is the intriguing question that a team of investigators from Case Western Reserve University School of Medicine and Cleveland Clinic seeks to answer. In a review article recently published in Birth Defects Research, the trio of researchers supplies a rationale for the use of exercise, particularly assisted exercise, in the prevention and adjunctive treatment of substance-use disorders – including alcohol, marijuana, cocaine, opioids, and heroin.
Although it has been known that alterations in the connections between neurons in the brain likely play a role in alcohol dependence and other addictions, the cause-and-effect between these brain alterations and behavior has been less clear.